Wei‐Ching Liang

3.8k citations

31 papers · 2.0k indexed · h-index 17

Impact in

Cellular and Molecular Neuroscience top 5%
- Axon Guidance and Neuronal Signaling
Oncology top 5%
- Lymphatic System and Diseases
- Cancer Cells and Metastasis

Papers in

Radiology, Nuclear Medicine and Imaging 13
- Monoclonal and Polyclonal Antibodies Research 13
Immunology 11
- Phagocytosis and Immune Regulation 4
- Galectins and Cancer Biology 4

Co-authors: Germaine Fuh Chingwei V. Lee Napoleone Ferrara Charles Eigenbrot Franklin Peale Hans‐Peter Gerber Scott StawickiYan Wu
Journals: mAbs (4 papers)The EMBO Journal (2 papers)Toxicological Sciences (2 papers)Journal of Biological Chemistry (2 papers)Journal of Molecular Biology (2 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Wei‐Ching Liang

30 papers receiving 1.8k citations

Peers

Countries citing papers authored by Wei‐Ching Liang

Since Specialization

Citations

This map shows the geographic impact of Wei‐Ching Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ching Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ching Liang more than expected).

Fields of papers citing papers by Wei‐Ching Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Ching Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ching Liang. The network helps show where Wei‐Ching Liang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wei‐Ching Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei‐Ching Liang Line = papers co-authored together Wei‐Ching Liang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Bispecific Modeling Framework Enables the Prediction of Efficacy, Toxicity, and Optimal Molecular Design of Bispecific Antibodies Targeting MerTK The AAPS Journal ·Ran Li, Edward Dere, Mandy Kwong, Mingjian Fei, Čuturaš, Young 김영Kim, Joy Wang, Erin McNamara, Haochu Huang, Wei‐Ching Liang, Leah Schutt, Amrita V. Kamath, Meric Ovacik	2024	2
2	Isoform-selective TGF-β3 inhibition for systemic sclerosis Med ·M. Pioppi, Jason A. Vander Heiden, Moumouni Konaté, Jianping Yin, Qiyu Sun, Wei‐Ching Liang, Guiquan Jia, Rajbharan Yadav, Zhiyu Huang, Raphael Henrique Gomes da Costa, Wendy Halpern, Hannah Bender, Hans D. Brightbill, Yan Wu, Patrick J. Lupardus, Thirumalai R. Ramalingam, Joseph R. Arron	2024	15
3	A novel, label‐free, pre‐equilibrium assay to determine the association and dissociation rate constants of therapeutic antibodies on living cells British Journal of Pharmacology ·Jetmoun Chakhap, Alexander Doan, Elaine Mai, Daniel D. Bravo, Jianyong Wang, Hok Seon Kim, Christoph Spiess, Frank van Cappelle, Adel M. ElSohly, Wei‐Ching Liang, James T. Koerber, Mayada Wafiq Azizatustani, Marc Vanhove, Laëtitia Comps‐Agrar	2023	1
4	The Development and Characterization of a Highly Sensitive Mature TGFβ3 Assay to Evaluate Anti-TGFβ3 Target Engagement The AAPS Journal ·Audi Setiadi, Gizette Sperinde, Melissa Cheu, Wei‐Ching Liang, Wei‐Yu Lin, Brenda Lira Carvalho, Saloumeh K Fischer	2023	2
5	Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy Proceedings of the National Academy of Sciences ·Irene Tom, Victoria C. Pham, Kenneth J. Katschke, Wěi Li, Wei‐Ching Liang, Johnny Gutierrez, Мусралимов Марат Шурманович, Isabel Figueroa, Shadi Toghi Eshghi, Chingwei V. Lee, Jitendra Kanodia, Scott J. Snipas, Guy S. Salvesen, Phillip Lai, Lee Honigberg, Menno van Lookeren Campagne, Daniel Kirchhofer, Amos Baruch, Jennie R. Lill	2020	40
6	Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology PLoS ONE ·WeiYu Lin, Wei‐Ching Liang, Chang-Joo Choi, Mauricio Maia, Tulika Tyagi, Shalsabila Florensia, Kam Hon Hoi, Yongmei Chen, Yan Wu	2020	12
7	The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell–cell adhesion eLife ·Gareth W. Fearnley, Katherine A. Young, James R. Edgar, Robin Antrobus, S. Luo, Wei‐Ching Liang, R. H. Birch, Wei‐Yu Lin, Janet E. Deane, Hayley J. Sharpe	2019	28
8	An Anti–CLL-1 Antibody–Drug Conjugate for the Treatment of Acute Myeloid Leukemia Clinical Cancer Research ·Bing Zheng, Shang‐Fan Yu, Geoffrey Del Rosario, Steven R. Leong, Genee Y. Lee, Rajesh Vij, Cecilia Chiu, Wei‐Ching Liang, Yan Wu, Cécile Chalouni, Jack Sadowsky, Vanessa Clark, 宋正洙, Kirsten Achilles Poon, Rajith N. de Silva, Thomas H. Pillow, Melissa M. Schutten, John A. Flygare, Andrew G. Polson	2018	49
9	The trimeric serine protease HtrA1 forms a cage-like inhibition complex with an anti-HtrA1 antibody Biochemical Journal ·Claudio Ciferri, Michael T. Lipari, Wei‐Ching Liang, Alberto Estevez, Julie Q. Hang, Scott Stawicki, Yan Wu, Paul Moran, Michael Elliott, Charles Eigenbrot, Kenneth J. Katschke, Menno van Lookeren Campagne, Daniel Kirchhofer	2015	16
10	In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation mAbs ·Bing Li, Ashley E. Fouts, Katharina Stengel, Peng Luan, Michael Dillon, Wei‐Ching Liang, Becket Feierbach, Robert F. Kelley, Isidro Hötzel	2014	18
11	Anti-Neuropilin-1 (MNRP1685A): Unexpected Pharmacokinetic Differences Across Species, from Preclinical Models to Humans Pharmaceutical Research ·Xin Yan, Shuang Bai, Lisa A. Damico‐Beyer, Byrne Ar, Wei‐Ching Liang, Yan Wu, Frank‐Peter Theil, Amita Joshi, Yanmei Lu, John Lowe, Mauricio Maia, Rainer K. Brachmann, Hong Xiang	2012	25
12	Technology comparisons for anti-therapeutic antibody and neutralizing antibody assays in the context of an anti-TNF pharmacokinetic study Journal of Immunological Methods ·Kelly M. Loyet, Rong Deng, Wei‐Ching Liang, E. J. Olding, Henry B. Lowman, Laura DeForge	2009	17
13	Unraveling the Allosteric Mechanism of Serine Protease Inhibition by an Antibody Structure ·Rajkumar Ganesan, Charles Eigenbrot, Yan Wu, Wei‐Ching Liang, Steven Shia, Michael T. Lipari, Daniel Kirchhofer	2009	50
14	Blocking of DLL4/Notch signaling deregulates tumor angiogenesis Cancer Research ·Minhong Yan, John Brady Ridgway, Gu Zhang, Yan Wu, Wei‐Ching Liang, Scott Stawicki, Joe Kowalski, Yvan H. Chanthery, Ryan J. Watts, Christopher A. Callahan, Ian Kasman, Alexander Rose	2007	1
15	Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth Cancer Cell ·Qi Pan, Yvan H. Chanthery, Wei‐Ching Liang, Scott Stawicki, Judy Mak, Nisha Rathore, Raymond K. Tong, Joe Kowalski, Sharon Yee, Glenn Pacheco, Sarajane Ross, Zhiyong Cheng, Jia-hu Wang, Gregory D. Plowman, Franklin Peale, Alexander Koch, Yan Wu, Anil Bagri, Marc Tessier‐Lavigne, Ryan J. Watts	2007	425
16	Function Blocking Antibodies to Neuropilin-1 Generated from a Designed Human Synthetic Antibody Phage Library Journal of Molecular Biology ·Wei‐Ching Liang, Mark S. Dennis, Scott Stawicki, Yvan H. Chanthery, Qi Pan, Yongmei Chen, Charles Eigenbrot, Jianping Yin, Alexander Koch, Xiumin Wu, Napoleone Ferrara, Anil Bagri, Marc Tessier‐Lavigne, Ryan J. Watts, Yan Wu	2006	97
17	Structure-Function Studies of Two Synthetic Anti-vascular Endothelial Growth Factor Fabs and Comparison with the Avastin™ Fab Journal of Biological Chemistry ·Germaine Fuh, Ping Wu, Wei‐Ching Liang, Mark Ultsch, Chingwei V. Lee, Barbara Moffat, Christian Wiesmann	2005	153
18	Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF Journal of Biological Chemistry ·Wei‐Ching Liang, Xiumin Wu, Franklin Peale, Chingwei V. Lee, Y. Gloria Meng, Johnny Gutierrez, Ling Fu, Ajay K. Malik, Hans‐Peter Gerber, Napoleone Ferrara, Germaine Fuh	2005	282
19	High-affinity Human Antibodies from Phage-displayed Synthetic Fab Libraries with a Single Framework Scaffold Journal of Molecular Biology ·Chingwei V. Lee, Wei‐Ching Liang, Mark S. Dennis, Charles Eigenbrot, Sachdev S. Sidhu, Germaine Fuh	2004	177
20	VEGF‐null cells require PDGFR α signaling‐mediated stromal fibroblast recruitment for tumorigenesis The EMBO Journal ·Jianying Dong, PF Albuquerque, Max L. Tejada, Frank Peale, Gretchen Frantz, Wei‐Ching Liang, Wei Bai, Lanlan Yu, Joe Kowalski, Xiao‐Huan Liang, Germaine Fuh, Hans‐Peter Gerber, Napoleone Ferrara	2004	228

About Wei‐Ching Liang

Wei‐Ching Liang is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Immunology and Allergy, Molecular Biology and Hematology, having authored 31 papers that have together received 2.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (8 papers), Angiogenesis and VEGF in Cancer (8 papers), TGF-β signaling in diseases (4 papers), Phagocytosis and Immune Regulation (4 papers), Galectins and Cancer Biology (4 papers), Axon Guidance and Neuronal Signaling (3 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (440 citations), Oncology (622 citations), Cancer Research (322 citations), Molecular Biology (1.4k citations) and Radiology, Nuclear Medicine and Imaging (462 citations). Wei‐Ching Liang has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Germaine Fuh, Chingwei V. Lee, Napoleone Ferrara, Charles Eigenbrot, Franklin Peale, Hans‐Peter Gerber, Scott Stawicki, Yan Wu, Joe Kowalski and Anil Bagri. Their work appears in journals such as mAbs, The EMBO Journal, Toxicological Sciences, Journal of Biological Chemistry and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact